PMV PHARMACEUTICALS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
PMV PHARMACEUTICALS, INC. (PMVP) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 45.57 million shares for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-08-09
- PMV PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-06-30 was 45.57M shares, a 1.11% increase year-over-year.
- PMV PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 45.47M shares, a 1.52% increase year-over-year.
- PMV PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 45.39M shares, a 0.16% increase year-over-year.
- PMV PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 45.30M shares, a 652.11% increase year-over-year.
- PMV PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 45.14M shares, a 214.23% increase from fiscal 2020.
- PMV PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 14.36M shares, a 373.26% increase from fiscal 2019.
- PMV PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 3.04M shares, a 0.76% increase from fiscal 2018.
- PMV PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 3.01M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-06-30 | 45.57M shares 10-Q · filed 2022-08-09 | 45.52M shares 10-Q · filed 2022-08-09 | 45.48M shares derived: average of 3 quarters · filed 2022-08-09 | 45.43M shares derived: average of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | 45.47M shares 10-Q · filed 2022-05-10 | 45.43M shares derived: average of 2 quarters · filed 2022-05-10 | 45.39M shares derived: average of 3 quarters · filed 2022-05-10 | 45.31M shares derived: average of 4 quarters · filed 2022-08-09 |
| 2021-12-31 | 45.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 45.34M shares derived: average of 2 quarters · filed 2022-03-01 | 45.25M shares derived: average of 3 quarters · filed 2022-08-09 | 45.14M shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 45.30M shares 10-Q · filed 2021-11-12 | 45.18M shares derived: average of 2 quarters · filed 2022-08-09 | 45.05M shares 10-Q · filed 2021-11-12 | 45.12M shares derived: average of 4 quarters · filed 2022-08-09 |
| 2021-06-30 | 45.07M shares 10-Q · filed 2022-08-09 | 44.93M shares 10-Q · filed 2022-08-09 | 45.06M shares derived: average of 3 quarters · filed 2022-08-09 | 35.30M shares derived: average of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | 44.79M shares 10-Q · filed 2022-05-10 | 45.05M shares derived: average of 2 quarters · filed 2022-05-10 | 32.04M shares derived: average of 3 quarters · filed 2022-05-10 | 24.79M shares derived: average of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | 45.32M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 25.67M shares derived: average of 2 quarters · filed 2022-03-01 | 18.13M shares derived: average of 3 quarters · filed 2022-03-01 | 14.36M shares 10-K · filed 2022-03-01 |
| 2020-09-30 | 6.02M shares 10-Q · filed 2021-11-12 | 4.53M shares derived: average of 2 quarters · filed 2021-11-12 | 4.05M shares 10-Q · filed 2021-11-12 | 3.79M shares derived: average of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | 3.05M shares 10-Q · filed 2021-08-13 | 3.05M shares 10-Q · filed 2021-08-13 | 3.05M shares derived: average of 3 quarters · filed 2022-03-01 | 3.05M shares derived: average of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | 3.05M shares 10-Q · filed 2021-05-14 | 3.05M shares derived: average of 2 quarters · filed 2022-03-01 | 3.05M shares derived: average of 3 quarters · filed 2022-03-01 | |
| 2019-12-31 | 3.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 3.05M shares derived: average of 2 quarters · filed 2022-03-01 | 3.04M shares 10-K · filed 2022-03-01 | |
| 2019-09-30 | 3.05M shares 10-Q · filed 2020-11-13 | 3.03M shares 10-Q · filed 2020-11-13 | ||
| 2018-12-31 | 3.01M shares 10-K · filed 2021-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |